Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Ovulation induction, IUI and IVF concepts

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Ovarian stimulation requires a safety system

Gonadotrophin treatment can cause excessive follicular response, multiple pregnancy and ovarian hyperstimulation syndrome, while post-procedure pain or bleeding may signal torsion, infection or internal bleeding.

Action: Use specialist protocols with ultrasound monitoring and cancellation criteria, provide a 24-hour contact route, and assess severe pain, respiratory symptoms, oliguria, bleeding, collapse or thrombotic symptoms urgently.

Synopsis

Match ovulation induction, intrauterine insemination, IVF and ICSI to the diagnosed fertility problem, explain a full treatment cycle, reduce multiple pregnancy and avoid ineffective add-ons.

  • Ovulation induction treats a defined ovulatory disorder; it is not recommended as stand-alone treatment for unexplained infertility.
  • Letrozole is the preferred first-line pharmacological ovulation induction for anovulatory infertility in PCOS in the 2023 international guideline, but its UK fertility use is off-label and requires informed specialist prescribing.
  • Gonadotrophin induction requires ultrasound monitoring of follicle number and size to reduce multiple pregnancy and OHSS.
  • IUI places prepared sperm in the uterine cavity around ovulation; it does not bypass bilateral tubal occlusion and relies on a suitable total motile sperm population.
  • After 2 total years of unexplained infertility, NG257 says discuss either up to 4 cycles of gonadotrophin-stimulated IUI before IVF, or IVF directly, according to benefits, risks and preference.
  • IVF uses ovarian stimulation, oocyte retrieval, laboratory fertilisation, embryo culture and transfer; a full cycle includes one stimulation and transfer of all resulting fresh and frozen embryos.
  • ICSI is offered with surgically retrieved sperm or frozen-thawed oocytes and considered for sufficiently abnormal semen or previous failed or very low fertilisation, not routinely when semen is normal.
  • Use single embryo transfer wherever recommended, never transfer more than two embryos, and avoid endometrial scratch, routine pre-IVF hysteroscopy, receptivity tests, PGT-A to improve live birth and immunological add-ons.

Key red flags

Rapid abdominal distension, severe pain, persistent vomiting, dyspnoea, reduced urine output, syncope or leg or chest symptoms after stimulation requires urgent OHSS and thrombosis assessment.

Sudden focal pelvic pain with nausea after ovarian stimulation may represent adnexal torsion and needs urgent gynaecological assessment.

Heavy bleeding, shoulder-tip pain, collapse or peritoneal signs after oocyte retrieval requires urgent review for intra-abdominal bleeding or other procedural complication.

Fever, escalating pelvic pain or offensive discharge after insemination, retrieval or transfer suggests infection.

A positive pregnancy test with pain or bleeding after assisted conception still requires ectopic and heterotopic pregnancy assessment.

Investigation priorities

01
Complete fertility assessmentFirst step

Confirm ovulatory, tubal, uterine and semen factors before selecting treatment.

Management branches

Ovulation inductionAim for safe monofollicular ovulation

A treatable anovulatory disorder is confirmed.

  1. Correct reversible central or endocrine causes and exclude pregnancy, important tubal disease and major semen factors before induction.
  2. Use diagnosis-specific treatment such as off-label letrozole for anovulatory PCOS, cabergoline for hyperprolactinaemia or gonadotrophin/GnRH therapy for hypogonadotrophic hypogonadism.
  3. Monitor gonadotrophin cycles with ultrasound, apply cancellation rules and counsel about multiple pregnancy, OHSS and timed intercourse or insemination.

Key medicines

LetrozoleA common specialist regimen is 2.5 mg orally once daily for 5 days early in the cycle, with any escalation determined by the fertility protocol and response.Fertility use is off-label in the UK. Exclude pregnancy, explain off-label use, and avoid unmonitored repeat cycles or use when tubal or semen factors make induction inappropriate.
GonadotrophinsProduct and starting dose are individualised to diagnosis, AMH or AFC, age and prior response, then adjusted only within a specialist protocol.Multiple pregnancy and OHSS; do not use without ultrasound access, predefined adjustment and cancellation criteria, and a 24-hour advice pathway.
Open full textbook →Answer 2 questions
Sources and review status7 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG257 unexplained infertility treatment
  • NICE NG257 IVF access criteria
  • NICE NG257 IVF procedures
  • NICE NG257 female-factor management
  • NICE NG257 ICSI recommendations
  • HFEA in vitro fertilisation
  • International evidence-based PCOS guideline 2023

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Rapid draft
Authoring state
Clinical stateAwaiting review
JurisdictionUnited Kingdom